Novo Nordisk Takes $820 Million Charge on Failed Heart Drug

Novo Nordisk A/S said it will take an impairment of about 5.7 billion Danish kroner ($820 million) after halting a late-stage study of an experimental heart drug it acquired last year.



Source link
lol